Indications and uses
Helps treat and prevent diaper rash. Protects chafed skin due to diaper rash. Helps seal out wetness.
Hipoglós ® Ointment
- Manufacturer
- Laboratorios Andromaco S.A.
- Effective date
- 2013-11-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 12
- Source
- full-release
- Hydrated at
- 2026-05-31 22:37:21
Label at a glance#
ProductHipoglos
Active ingredientZINC OXIDE, LANOLIN
Label structure17 sections
Dosage and administration
Change wet or soiled diapers promptly. Clean the diaper area. Allow to dry. Apply ointment liberally as often as necessary, with each diaper change, especially at bedtime or any time when exposure to wet diapers may be prolonged.
Storage and handling
Store at 59° to 86° F (15 ° to 30° C)
Label contents#
Full prescribing information#
Active ingredient
Lanolin USP 15%
Zinc Oxide 15%
Purpose
Skin Protectant
Uses
- Helps treat and prevent diaper rash.
- Protects chafed skin due to diaper rash.
- Helps seal out wetness.
Warnings
For external use only
When using this product - do not get into eyes
Stop use and ask a doctor if:
- Conditions worsen.
- Symptoms last more than 7 days or clear up and occur again within a few days.
Do not use on:
- Deep or puncture wounds
- Animal Bites
- Serious Burns
Keep out of reach of children
- If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Change wet or soiled diapers promptly.
- Clean the diaper area.
- Allow to dry.
- Apply ointment liberally as often as necessary, with each diaper change, especially at bedtime or any time when exposure to wet diapers may be prolonged.
Other Information
Store at 59° to 86° F (15 ° to 30° C)
Inactive ingredients
Alcohol, Benzethonium Chloride, Cod Liver Oil (contains vitamin A and D), Lavender Fragrance, Mineral Oil, Petrolatum, Sorbitan Monostearate, Talc, Vanillin, and Water.
Propósito
Protector dérmico
Usos
- Ayuda a tratar y prevenir las irritaciones producidas por el pañal.
- Protege la piel irritada debido a las rozaduras de pañal.
- Ayuda a mantener la piel seca.
Warnings
Para uso externo
*Cuando use este producto no aplicar en los ojos.
Descontinuar su uso y preguntar al médico si:
• la condición empeora
• Los síntomas permanecen por más de 7 días o si desaparecen y vuelven a aparecer luego de pocos días.
No usar en:
• Heridas profundas y punzantes.
• Mordeduras de animales
• Quemaduras graves
Mantener fuera del alcance de los niños
* Si son ingeridos, consiga ayuda médica o acuda al Centro de Control de Envenenamiento inmediatamente.
Indicaciones de uso
- Cambiar pañales mojados o sucios rápidamente.
- Limpie la zona del pañal.
- Deje secar.
- Aplicar ungüento libremente de acuerdo a necesidad, con cada muda del pañal, especialmente a la hora de dormir o cuando la exposición a pañales mojados se prolongue más de lo habitual.
Otra información
*Almacenar entre 59° y 86° F (15 y 30°C).
Excipientes
alcohol, cloruro de bencetonio, aceite de hígado de bacalao (contiene vitaminas A y D), esencia de lavanda, aceite mineral, petrolato blanco, monoestearato de sorbitan, talco, vainillina, agua.
Principal Display Panel - Carton Label
Carton Label
Hipoglós® Ointment
Helps prevent and treat diaper rash, skin irritation
Net wt. 4.2 oz (120 g)
Principal Display Panel - Tube Label
Tube Label
Hipoglós® Ointment
Helps prevent and treat diaper rash, skin irritation
Net wt. 4.2 oz (120 g)
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1249131 | lanolin 15 % / zinc oxide 15 % Topical Ointment | PSN | 12 |
| 1249131 | lanolin 0.15 MG/MG / zinc oxide 0.15 MG/MG Topical Ointment | SCD | 12 |
| 1249131 | Lanolin 0.15 MG/MG / ZNO 0.15 MG/MG Topical Ointment | SY | 12 |
| 1249131 | lanolin 15 % / zinc oxide 15 % Topical Ointment | SY | 12 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50145-222-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4b63-60a7-e053-dbdaa90a05bd | Hipoglós ® Ointment |
| 50145-222-02 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4b63-60a7-e053-dbdaa90a05bd | Hipoglós ® Ointment |
| 50145-222-03 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4b63-60a7-e053-dbdaa90a05bd | Hipoglós ® Ointment |
| 50145-222-04 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4b63-60a7-e053-dbdaa90a05bd | Hipoglós ® Ointment |
| 50145-222-05 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4b63-60a7-e053-dbdaa90a05bd | Hipoglós ® Ointment |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50145-222-01 | Hipoglos | 120 g in 1 TUBE | OINTMENT | 120 | 12 | |
| 50145-222-01 | Hipoglos | 1 in 1 CARTON | OINTMENT | 1 | 12 | |
| 50145-222-02 | Hipoglos | 100 g in 1 TUBE | OINTMENT | 100 | 12 | |
| 50145-222-02 | Hipoglos | 1 in 1 CARTON | OINTMENT | 1 | 12 | |
| 50145-222-03 | Hipoglos | 1 in 1 CARTON | OINTMENT | 1 | 12 | |
| 50145-222-03 | Hipoglos | 72 g in 1 TUBE | OINTMENT | 72 | 12 | |
| 50145-222-04 | Hipoglos | 60 g in 1 TUBE | OINTMENT | 60 | 12 | |
| 50145-222-04 | Hipoglos | 1 in 1 CARTON | OINTMENT | 1 | 12 | |
| 50145-222-05 | Hipoglos | 5 g in 1 TUBE | OINTMENT | 5 | 12 | |
| 50145-222-05 | Hipoglos | 1 in 1 CARTON | OINTMENT | 1 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LANOLIN | ACTIVE INGREDIENT | 7EV65EAW6H | 12 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 12 | |
| LANOLIN | ACTIVE MOIETY | 7EV65EAW6H | 12 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 12 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 12 | |
| BENZETHONIUM CHLORIDE | INACTIVE INGREDIENT | PH41D05744 | 12 | |
| COD LIVER OIL | INACTIVE INGREDIENT | BBL281NWFG | 12 | |
| ENGLISH LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 12 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 12 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 12 | |
| SORBITAN MONOSTEARATE | INACTIVE INGREDIENT | NVZ4I0H58X | 12 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 12 | |
| VANILLIN | INACTIVE INGREDIENT | CHI530446X | 12 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 12 |
Products#
Every source-derived product name is available through these pages.
- Hipoglos
- Zinc Oxide and Lanolin
- ZINC OXIDE
- LANOLIN
- ALCOHOL
- BENZETHONIUM CHLORIDE
- COD LIVER OIL
- ENGLISH LAVENDER OIL
- MINERAL OIL
- PETROLATUM
- SORBITAN MONOSTEARATE
- TALC
- VANILLIN
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50145-222 | 50145-222-01, 50145-222-02, 50145-222-03, 50145-222-04, 50145-222-05 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ZINC OXIDE | SOI2LOH54Z | ACTIB |
| LANOLIN | 7EV65EAW6H | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| BENZETHONIUM CHLORIDE | PH41D05744 | IACT |
| COD LIVER OIL | BBL281NWFG | IACT |
| ENGLISH LAVENDER OIL | ZBP1YXW0H8 | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| SORBITAN MONOSTEARATE | NVZ4I0H58X | IACT |
| TALC | 7SEV7J4R1U | IACT |
| VANILLIN | CHI530446X | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TALC | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUPPOSITORY / VAGINAL | NA | ||
| ENGLISH LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | INHALANT / NASAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | CREAM / TOPICAL | 177 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| VANILLIN | VANILLIN | CHI530446X | LIQUID / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUSPENSION / ORAL | 62.5 mg/5ml | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, EXTENDED RELEASE / ORAL | 3.4 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| BENZETHONIUM CHLORIDE | BENZETHONIUM CHLORIDE | PH41D05744 | INJECTION / INTRAMUSCULAR | 1 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ENGLISH LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | GEL / TOPICAL | 0.1 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, FILM COATED / ORAL | 5 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | TABLET / ORAL | 4 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TALC | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 62bb10cd-4e99-4e93-a7f5-9dabf692a2d6 | 8e486fed-2316-4297-99d3-9b1a7904d0a7 | 2013-11-02 | Warnings | 62bb10cd-4e99-4e93-a7f5-9dabf692a2d6 8e486fed-2316-4297-99d3-9b1a7904d0a7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.